PCHM Stock Overview
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
PharmChem, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.73 |
| 52 Week High | US$3.57 |
| 52 Week Low | US$2.10 |
| Beta | 0 |
| 1 Month Change | 4.20% |
| 3 Month Change | 6.64% |
| 1 Year Change | -4.21% |
| 3 Year Change | -40.52% |
| 5 Year Change | 187.37% |
| Change since IPO | -70.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| PCHM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.7% | 1.6% | 1.0% |
| 1Y | -4.2% | -1.4% | 21.9% |
Return vs Industry: PCHM underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: PCHM underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| PCHM volatility | |
|---|---|
| PCHM Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PCHM's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PCHM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Thompson Clark | www.pharmchek.com |
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.
PharmChem, Inc. Fundamentals Summary
| PCHM fundamental statistics | |
|---|---|
| Market cap | US$12.69m |
| Earnings (TTM) | -US$2.04m |
| Revenue (TTM) | US$25.73m |
0.0x
P/S Ratio0.0x
P/E RatioIs PCHM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PCHM income statement (TTM) | |
|---|---|
| Revenue | US$25.73m |
| Cost of Revenue | US$19.98m |
| Gross Profit | US$5.74m |
| Other Expenses | US$7.78m |
| Earnings | -US$2.04m |
Last Reported Earnings
Mar 31, 2004
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PCHM perform over the long term?
See historical performance and comparison